Abstract
Get full access to this article
View all access options for this article.
References
1.
Younossi
ZM
McHutchinson
JG
Ganiats
TG
. An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis . J Hepatol
1997 ;27 : 295 –8 .
2.
Navasa
M
Rimola
A
Rodes
J
. Bacterial infections in liver disease . Semin Liver Dis
1997 ;17 : 323 –33 .
3.
Arroyo
V
Navasa
M
Rimola
A
. Spontaneous bacterial peritonitis in liver cirrhosis: Treatment and prophylaxis . Infection
1994 ;22 (Suppl ):S167 –75 .
4.
Wathen
CG
MacDonald
T
Wise
LA
Boyd
SM
. Eosinophilia associated with spironolactone . Lancet
1986 ;1 : 919 –20 .
5.
Cleau
D
Jobard
JM
Alves
T
Gury
S
Rey
B
Vuillemard
M
Cholestatic hepatitis induced by the amoxicillin-clavulanic acid combination. A case and review of the literature . Gastroenterol Clin Biol
1990 ;14 : 1007 –9 .
6.
Naranjo
CA
Busto
U
Sellers
EM
Sandor
P
Ruiz
I
Roberts
EA
A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther
1981 ;30 : 239 –45 .
7.
Davoren
P
Mainstone
K
. Norfloxacin-induced hepatitis . Med J Aust
1993 :159 :423 –6 .
8.
Corrado
ML
Struble
WE
Peter
C
Hoagland
V
Sabbaj
J
. Norfloxacin: Review of safety studies . Am J Med
1987 ;26 : 22 –6 .
9.Product information . Norfloxacin . [accessed 2002 May 7]. Available from: URL: http://www.fda.gov/cder/foi/label/2001/19384s39lbl.pdf.